Literature DB >> 3010640

Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.

J Pernow, A Saria, J M Lundberg.   

Abstract

The effects of porcine neuropeptide Y (NPY) regarding sympathetic vascular control were studied in vitro on isolated rat blood vessels. The 10(-9)M NPY enhanced (about two-fold) the contractile responses to transmural nerve stimulation (TNS), noradrenaline (NA) and adrenaline (about two-fold) in the femoral artery. Higher concentrations of NPY (greater than 10(-8)M) caused an adrenoceptor-resistant contraction per se. The TNS-evoked [3H]NA efflux was significantly reduced by NPY in a concentration-dependent manner (threshold 10(-9)M). The calcium antagonist, nifedipine, abolished the contractile effects of NPY and the NPY-induced enhancement of NA contractions but did not influence the prejunctional inhibition of [3H]NA release. Receptor-binding studies showed that the ratio of alpha 1-to alpha 2-adrenoceptors in the femoral artery was 30:1. The NPY did not cause any detectable change in the number of alpha 1-or alpha 2-adrenoceptor binding sites or in the affinity of alpha 2-binding sites, as revealed by prazosin- and clonidine-binding, respectively. The NPY also inhibited the TNS-evoked [3H]NA release (by 42-86%) in the superior mesenteric and basilar arteries and in femoral and portal veins. The NPY still depressed TNS-evoked [3H]NA secretion from the portal vein in the presence of phentolamine. The NPY caused a clear-cut contraction in the basilar artery, increased the contractile force of spontaneous contractions in the portal vein, while only weak responses were observed in the superior mesenteric artery and femoral vein. The NA-induced contraction was markedly enhanced by NPY in the superior mesenteric artery, only slightly enhanced in the portal vein and uninfluenced in the femoral vein. In conclusion, in all blood vessels tested, NPY depresses the TNS-evoked [3H]NA secretion via a nifedipine-resistant action. Furthermore, NPY exerts a variable, Ca2+-dependent vasoconstrictor effect and enhancement of NA and TNS contractions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010640     DOI: 10.1111/j.1748-1716.1986.tb07811.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  21 in total

Review 1.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).

Authors:  M Adamsson; B Fallgren; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Chemical sympathectomy reveals pre- and postsynaptic effects of neuropeptide Y (NPY) in the cardiovascular system.

Authors:  Y Mabe; R Pérez; K Tatemoto; J P Huidobro-Toro
Journal:  Experientia       Date:  1987-09-15

4.  Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study.

Authors:  D M Levy; S S Karanth; D R Springall; J M Polak
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

5.  Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.

Authors:  R E Malmström
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.

Authors:  J Pernow; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

7.  Evoked noradrenaline release in the rabbit ear artery: enhancement by purines, attenuation by neuropeptide Y and lack of effect of calcitonin gene-related peptide.

Authors:  K I Maynard; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Effect of neuropeptide Y on adrenergic and non-adrenergic, non-cholinergic responses in the rat anococcygeus muscle.

Authors:  E Vila; A Tabernero; F Fernandes; M Salaices
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Neuropeptide Y potentiates calcium-channel currents in single vascular smooth muscle cells.

Authors:  Z Xiong; B J Bolzon; D W Cheung
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

10.  Survival of trauma-injured neurons in rat brain by treatment with proline-rich peptide (PRP-1): an immunohistochemical study.

Authors:  Silva S Abrahamyan; John S Sarkissian; Irina B Meliksetyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.